The effect of probiotic use on fasting glycemia, insulin resistance and glycated hemoglobin in people with type 2 Diabetes mellitus: a literature review
DOI:
https://doi.org/10.33448/rsd-v11i5.27972Keywords:
Probiotics; Type 2 Diabetes Mellitus; Blood glucose; Insulin resistance; Glycated hemoglobin A.Abstract
The aim of this study is to summarize the evidence in the literature about the effect of probiotics on glycemic control in patients with type 2 diabetes mellitus (T2DM). This is an integrative literature review to answer the question: “What is the evidence on the use of probiotics to reduce fasting glucose and/or glycated hemoglobin and/or insulin resistance in people with T2DM”. The search was performed in the Medline-PubMed, Cochrane Library and Bireme databases using descriptors combined using the OR and AND operators. Randomized clinical trials performed with adult humans diagnosed with T2DM and which evaluated at least one of the outcomes of interest were included. The search resulted in 207 articles, of which 14 were included. The duration of the intervention ranged from 6 weeks to 6 months, the number of strains from 1 to 14, the daily dose from 106 to 1010 CFU. Most studies included Lactobacillus and Bifidobacterium. The species and strains that appeared the most were Lactobacillus acidophilus, Lactobacillus casei, Bifidobacterium lactis and Streptococcus Thermophilus. It is suggested that the use of probiotics may be a strategy for managing T2DM, as most studies have shown a positive effect on at least one of the parameters.
References
Akbari, V.; & Hendijani, F. (2016). Effects of probiotic supplementation in patients with type 2 diabetes: systematic review and meta-analysis. Nutrition Reviews, Oxford, 74 (12), 774-784.
American Diabetes Association (2019). Standards of medical care in diabetes. Diabetes Care, 42.
Asemi, Z., Zare, Z., Shakeri, H., Sabihi, A., & Esmaillzadeh, A (2013). Effect of Multispecies Probiotic Supplements on Metabolic Profiles, hs-CRP, and Oxidative Stress in Patients with Type 2 Diabetes. Annals Nutrition and Metabolism, 63, 1-9.
Botelho, L. L. R., Cunha, C. C. de A. & Macedo, M. (2011). O método da revisão integrativa nos estudos organizacionais. Gestão E Sociedade, 5 (11), 121–136.
Ejtahed, H. S., Mohtadi-nia, J., Homayouni-rad, Z., Niafar, M., Asghari-Jafarabadi, M., & Mofid, V. (2012). Probiotic yogurt improves antioxidant status in type 2 diabetic patients. Nutrition, 28 (5), 539-543.
FAO/WHO (2006). Probiotics in food: Health and nutritional properties and guidelines for evaluation. FAO Food and nutrition Paper, 85.
Feizollahzadeh, S., Ghiasvand, R., Rezaei, A.; Khanahmad, H., Sadeghi, A., & Hariri, M. (2017). Effect of Probiotic Soy Milk on Serum Levels of Adiponectin, Inflammatory Mediators, Lipid Profile, and Fasting Blood Glucose Among Patients with Type II Diabetes Mellitus. Probiotics and Antimicrobial Proteins, 9 (1), 41-47.
Firouzi, S., Majid, H. A., Ismail, A., Kamaruddin, N. A., & Barakatun Nisak, M. Y. (2017). Effect of multi strain probiotics (multi strain microbial cell preparation) on glycemic control and other diabetes related outcomes in people with type 2 diabetes: a randomized controlled trial. European Journal of Nutrition, 56 (4), 1535-1550.
Harkins, C. P., Kong, H. H., & Segre, J. A. (2020) Manipulating the human microbiome to manage disease. JAMA, 323 (4), 303–304.
Hsieh, M., Tsai, W. H., Jheng, Y. P., Su, S., Wang, S. Y., Lin, C. C., Chen, Y. H., & Chang, W. W. (2018). The beneficial effects of Lactobacillus reuteri ADR-1 or ADR-3 consumption on type 2 diabetes mellitus: a randomized, doubleblinded, placebo-controlled trial. Scientific Reports, 8.
International Diabetes Federation (2017). IDF Atlas (8ª ed.) Bruxelas: International Diabetes Federation.
Jiang, H., Zhang, U., Xu, D., & Wang, Q. (2021). Probiotics ameliorates glycemic control of patients with diabetic nephropathy: A randomized clinical study. Journal of Clinical Laboratory Analysis, 35 (4).
Khalili, L., Alipour, B., Jafar-Abadi, M. A., Faraji, I., Hassanalilou, T., Abbasi, M. M., Vaghef-Mehrabany, E., et al. (2019). The Effects of Lactobacillus casei on Glycemic Response, Serum Sirtuin1 and Fetuin-A Levels in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial. Iranian Biomedical Journal, 23 (1), 68-77.
Kobyliak, N., Falalyeyeva, T., Mykhalchyshyn, G., Kyriienko, D., & Komissarenko, I. (2018). Effect of alive probiotic on insulin resistance in type 2 diabetes patients: randomized clinical trial. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 12 (5), 617-624.
Madempudi, R. S., Ahire, J. J., Neelamraju, D., Tripathi, A., & Nanal, S. (2019). Efficacy of UB0316, a multi-strain probiotic formulation in patients with type 2 diabetes mellitus: A double blind, randomized, placebo controlled study. Plos One, 14 (11).
Mendes, K. D. S. Silveira, R. C. C. P. & Galvão, C. M. (2008). Revisão integrativa: método de pesquisa para a incorporação de evidências na saúde e na enfermagem. Texto e Contexto Enfermagem , 17(4)758 - 764.
Mobini, R., Tremaroli, V., Ståhlman, M., Karlsson, F., Levin, M., Ljungberg, M., Sohlin, M., et al. (2017). Metabolic effects of Lactobacillus reuteri DSM 17938 in Patients with Type 2 Diabetes: A Randomized Controlled Trial. Diabetes, Obesity and Metabolism, 19 (4), 579-589.
Patterson, E, Ryan, P. M., Cryan, J. F., Dinan, T. G., Ross, R. P., Fitzgerald, G. F., & Stanton, C. (2016). Gut microbiota, obesity and diabetes. Postgraduate Medical Journal, 92, (1087), 286- 300.
Razmpoosh, E., Javadi, A., Ejtahed, H. S., Mirmiran, P., Javadi, M., & Yousefinejad, A. (2018). The effect of probiotic supplementation on glycemic control and lipid profile in patients with type 2 diabetes: A randomized placebo controlled trial. Diabetology & Metabolic Syndrome, 13, (1), 175-182.
Rittiphairoj, T., Pongpirul, K., Janchot, K., Mueller, N. T., & Li, T. (2021). Probiotics Contribute to Glycemic Control in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Advances in Nutrition, 12 (3), 722-734.
Sociedade Brasileira de Diabetes (2019-2020). Diretrizes da Sociedade Brasileira de Diabetes 2019-2020. São Paulo: Clannad, 491p.
Sabico, S., Al Mashharawi, A., Al Daghri, N. M., Yakout, S., Alnaami, A. M., Alokail, M. S., & Mcternan, P. G. (2017). Effects of a multi strain probiotic supplement for 12 weeks in circulating endotoxin levels and cardiometabolic profiles of medication naïve T2DM patients: a randomized clinical trial. Journal of Translational Medicine, 15 (1).
Samah, S., Ramasamy, K., Lim, S. M., & Neoh, C. F. (2016). Probiotics for the Management of Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis. Diabetes Research and Clinical Practice, 118, 172-182.
Telo, G. H., Cureau, F. V., Szklo, M., Bloch, K. V., & Schaan, B. D. (2019). Prevalence of type 2 diabetes among adolescents in Brazil: Findings from Study of Cardiovascular Risk in Adolescents (ERICA). Pediatric Diabetes, 20 (4), 389-396.
Toejing, P., Khampithum, N., Sirilun, S., Chaiyasut, C., & Lailerd, N. (2021). Influence of Lactobacillus paracasei HII01 Supplementation on Glycemia and Inflammatory Biomarkers in Type 2 Diabetes: A Randomized Clinical Trial. Foods, 10 (7).
Tonucci, L. B.; Santos, K. M. O., Oliveira, L. L.; Ribeiro, S. M. R.; & Martino, H. S. D. M. (2017). Clinical application of probiotics in type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled study. Clinical Nutrition, 36 (1), 85-92.
Yao, K., Zeng, L., He, Q., Wang, W., Lei, J., & Zou, X. (2017). Effect of Probiotics on Glucose and Lipid Metabolism in Type 2 Diabetes Mellitus: A Meta-Analysis of 12 Randomized Controlled Trials. Medical Science Monitor, 23, 3044-3053.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Mariana Pimentel Gomes Souza; Renata Cristina Machado Mendes; Dayanna Magalhães dos Reis; Maria Yasmin Paz Teixeira Martins
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
